Human-Centered Design Lessons for Implementation Science: Improving the Implementation of a Patient-Centered Care Intervention

Laura K Beres, Sandra Simbeza, Charles B Holmes, Chanda Mwamba, Njekwa Mukamba, Anjali Sharma, Virginia Munamunungu, Monica Mwachande, Kombatende Sikombe, Carolyn Bolton Moore, Aaloke Mody, Aybüke Koyuncu, Katerina Christopoulos, Lazarus Jere, Jake Pry, Peter D Ehrenkranz, Ashwin Budden, Elvin Geng, Izukanji Sikazwe, Laura K Beres, Sandra Simbeza, Charles B Holmes, Chanda Mwamba, Njekwa Mukamba, Anjali Sharma, Virginia Munamunungu, Monica Mwachande, Kombatende Sikombe, Carolyn Bolton Moore, Aaloke Mody, Aybüke Koyuncu, Katerina Christopoulos, Lazarus Jere, Jake Pry, Peter D Ehrenkranz, Ashwin Budden, Elvin Geng, Izukanji Sikazwe

Abstract

Background: Evidence-based HIV interventions often fail to reach anticipated impact due to insufficient utilization in real-world health systems. Human-centered design (HCD) represents a novel approach in tailoring innovations to fit end-users, narrowing the gap between efficacious interventions and impact at scale.

Methods: We combined a narrative literature review of HCD in HIV programs with our experience using HCD to redesign an intervention promoting patient-centered care (PCC) practices among health care workers (HCW) in Zambia. We summarize the use and results of HCD in the global HIV response and share case study insights to advance conceptualization of HCD applications.

Results: The literature review identified 13 articles (representing 7 studies) on the use of HCD in HIV. All studies featured HCD hallmarks including empathy development, user-driven inquiry, ideation, and iterative refinement. HCD was applied to mHealth design, a management intervention and pre-exposure prophylaxis delivery. Our HCD application addressed a behavioral service delivery target: changing HCW patient-centered beliefs, attitudes, and practices. Through in-depth developer-user interaction, our HCD approach revealed specific HCW support for and resistance to PCC, suggesting intervention revisions to improve feasibility and acceptability and PCC considerations that could inform implementation in transferable settings.

Conclusions: As both a research and implementation tool, HCD has potential to improve effective implementation of the HIV response, particularly for product development; new intervention introduction; and complex system interventions. Further research on HCD application strengths and limitations is needed. Those promoting PCC may improve implementation success by seeking out resonance and anticipating the challenges our HCD process identified.

Conflict of interest statement

P.D.E. works for the Bill & Melinda Gates Foundation. C.B.H. serves as a consultant to the Bill & Melinda Gates Foundation. The remaining authors have no conflicts of interest to disclose.

Figures

FIGURE 1.
FIGURE 1.
Narrative literature review HCD study inclusion.

References

    1. UNAIDS. Miles to Go: Closing Gaps, Breaking Barriers, Righting Injustices. Geneva, Switzerland: UNAIDS; 2018.
    1. El-Sadr WM, Harripersaud K, Rabkin M. Reaching global HIV/AIDS goals: what got us here, won't get us there. PLoS Med. 2017;14:e1002421.
    1. UNAIDS. Fast-Track: Ending the AIDS Epidemic by 2030. Geneva, Switzerland: UNAIDS; 2014.
    1. Geng EH, Holmes CB. Research to improve differentiated HIV service delivery interventions: learning to learn as we do. PLoS Med. 2019;16:e1002809.
    1. Ulett KB, Willig JH, Lin HY, et al. The therapeutic implications of timely linkage and early retention in HIV care. AIDS Patient Care STDS. 2009;23:41–49.
    1. Bazzano AN, Martin J, Hicks E, et al. Human-centred design in global health: a scoping review of applications and contexts. PLoS One. 2017;12:e0186744.
    1. Giacomin J. What is human centred design? Des J. 2014;17:606–623.
    1. Tolley E. Traditional Socio-Behavioral Research and Human-Centered Design: Similarities, Unique Contributions and Synergies. FHI 360; 2017. Available at:
    1. . The Field Guide to Human-Centered Design. 1st ed IDEO; 2015. Available at: .
    1. Wilson PA, Valera P, Martos AJ, et al. Contributions of qualitative research in informing HIV/AIDS interventions targeting black MSM in the United States. J Sex Res. 2016;53:642–654.
    1. Coughlin SS. Community-based participatory research studies on HIV/AIDS prevention, 2005-2014. Jacobs J Community Med. 2016;2:pii: 019.
    1. Teti M, Koegler E, Conserve DF, et al. A scoping review of photovoice research among people with HIV. J Assoc Nurses AIDS Care. 2018;29:504–527.
    1. Rhodes SD, Kelley C, Siman F, et al. Using community-based participatory research (CBPR) to develop a community-level HIV prevention intervention for Latinas: a local response to a global challenge. Womens Health Issues. 2012;22:e293–e301.
    1. Beach MC, Keruly J, Moore RD. Is the quality of the patient-provider relationship associated with better adherence and health outcomes for patients with HIV? J Gen Intern Med. 2006;21:661–665.
    1. Flickinger TE, Saha S, Moore RD, et al. Higher quality communication and relationships are associated with improved patient engagement in HIV care. J Acquir Immune Defic Syndr. 2013;63:362–366.
    1. Yehia BR, Mody A, Stewart L, et al. Impact of the outpatient clinic experience on retention in care: perspectives of HIV-infected patients and their providers. AIDS Patient Care STDS. 2015;29:365–369.
    1. Dang BN, Westbrook RA, Black WC, et al. Examining the link between patient satisfaction and adherence to HIV care: a structural equation model. PLoS One. 2013;8:e54729.
    1. Grant MJ, Booth A. A typology of reviews: an analysis of 14 review types and associated methodologies. Health Inf libraries J. 2009;26:91–108.
    1. Greenhalgh T, Robert G, Macfarlane F, et al. Diffusion of innovations in service organizations: systematic review and recommendations. Milbank Q. 2004;82:581–629.
    1. Zanolini A, Sikombe K, Sikazwe I, et al. Understanding preferences for HIV care and treatment in Zambia: evidence from a discrete choice experiment among patients who have been lost to follow-up. PLoS Med. 2018;15:e1002636.
    1. Topp SM, Mwamba C, Sharma A, et al. Rethinking retention: mapping interactions between multiple factors that influence long-term engagement in HIV care. PLoS One. 2018;13:e0193641.
    1. Mwamba C, Sharma A, Mukamba N, et al. They care rudely!: resourcing and relational health system factors that influence retention in care for people living with HIV in Zambia. BMJ Glob Health. 2018;3:e001007.
    1. Eshun-Wilson I, Mukumbwa-Mwenechanya M, Kim HY, et al. Differentiated care preferences of stable patients on ART in Zambia: a discrete choice experiment. J Acquir Immune Defic Syndr. 2019;81:540–546.
    1. Holmes CB. Estimated mortality on HIV treatment among active patients and patients lost to follow-up in 4 provinces of Zambia: findings from a multistage sampling-based survey. PLoS Med. 2018;15:e1002489.
    1. Patton MQ. Qualitative Research & Evaluation Methods. 3 ed. Thousand Oaks, CA: Sage Publications, Inc.; 2002.
    1. Lin A, Russell E, Tyler N. Dapivirine Ring Design Guide Human-Centered Design Research to Increase Uptake and Use. USAID; 2017. Available at: .
    1. Bautista-Arredondo S, Nance N, Salas-Ortiz A, et al. The role of management on costs and efficiency in HIV prevention interventions for female sex workers in Nigeria: a cluster-randomized control trial. Cost effectiveness and resource allocation. Cost Eff Resour Alloc. 2018;16:37.
    1. Catalani C, Green E, Owiti P, et al. A clinical decision support system for integrating tuberculosis and HIV care in Kenya: a human-centered design approach. PLoS One. 2014;9:e103205.
    1. Conrad I. Launching V A Human-Centered Approach to PrEP an Implementer's Guide. Arlington, TX: ; 2018. Available at: .
    1. Conrad V. Research Summary. Available at: . Accessed May 31, 2019.
    1. Erguera XA, Johnson MO, Neilands TB, et al. WYZ: a pilot study protocol for designing and developing a mobile health application for engagement in HIV care and medication adherence in youth and young adults living with HIV. BMJ Open. 2019;9:e030473.
    1. Ramos SR. User-centered design, experience, and usability of an electronic consent user interface to facilitate informed decision-making in an HIV clinic. Comput Inform Nurs. 2017;35:556–564.
    1. Schnall R, Bakken S, Rojas M, et al. mHealth technology as a persuasive tool for treatment, care and management of persons living with HIV. AIDS Behav. 2015;19(suppl 2):81–89.
    1. Schnall R, Rojas M, Travers J, et al. Use of design science for informing the development of a mobile app for persons living with HIV. AMIA Annu Symp Proc. 2014;2014:1037–1045.
    1. Schnall R, Bakken S, Brown W, et al. Usabilty evaluation of a prototype mobile app for health management for persons living with HIV. Stud Health Technol Inform. 2016;225:481–485.
    1. Schnall R, Rojas M, Bakken S, et al. A user-centered model for designing consumer mobile health (mHealth) applications (apps). J Biomed Inform. 2016;60:243–251.
    1. EMOTION—Enhancing Microbicide Uptake in High-Risk End Users. Available at: . Accessed May 31, 2019.
    1. Engage HCD. The Dapivirine Ring Design Guide Human-Centered Design Research to Increase Uptake and Use. Available at: . Accessed May 31, 2019.
    1. Were D, Atkins K, Musau A, et al. Manifestations of Stigma in the Context of a National Oral Pre Exposure Prophylaxis (PrEP) Scale-up Programme in Kenya. International AIDS Society Conference on HIV Science, Mexico City, Abstract MOAD0302. Mexico; 2019.
    1. Samuel K. Three Forms of PrEP Stigma in Kenya; 2019. Available at: . Accessed August 12, 2019.
    1. Manager HPM. End-User Research Landscape Mapping & Findings. New York, NY: AVAC; 2017.
    1. Montoya JL, Georges S, Poquette A, et al. Refining a personalized mHealth intervention to promote medication adherence among HIV+ methamphetamine users. AIDS Care. 2014;26:1477–1481.
    1. Garvie PA, Lawford J, Flynn PM, et al. Development of a directly observed therapy adherence intervention for adolescents with human immunodeficiency virus-1: application of focus group methodology to inform design, feasibility, and acceptability. J Adolesc Health. 2009;44:124–132.
    1. Guthrie KM, Rosen RK, Vargas SE, et al. User input in iterative design for prevention product development: leveraging interdisciplinary methods to optimize effectiveness. Drug Deliv Transl Res. 2017;7:761–770.
    1. Guthrie KM, Rohan L, Rosen RK, et al. Vaginal film for prevention of HIV: using visual and tactile evaluations among potential users to inform product design. Pharm Dev Technol. 2018;23:311–314.
    1. Terris-Prestholt F, Neke N, Grund JM, et al. Using discrete choice experiments to inform the design of complex interventions. Trials. 2019;20:157.
    1. Tobin GA, Begley CM. Methodological rigour within a qualitative framework. J Adv Nurs. 2004;48:388–396.
    1. Lin AH, Breger TL, Barnhart M, et al. Learning from the private sector: towards a keener understanding of the end-user for microbicide introduction planning. J Int AIDS Soc. 2014;17(3 suppl 2):19162.
    1. Cheney C. Gates Foundation and USAID Team up to Bring Design to Health: Inside Development Global Health; 2018. Available at: . Accessed May 31, 2019.
    1. IDEO. Empowering Women to Prevent HIV. 2019. Available at: .

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner